Neurokinin-3 receptor distribution in rat and human brain: An immunohistochemical study

Neuroscience

Volumn 89, Issue 4, 1999, Pages 1269-1290

  Mileusnic, D ^a   Lee, J M ^a   Magnuson, D J ^a   Hejna, M J ^a   Krause, J E ^c   Lorens, J B ^b   Lorens, S A ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoradiography; Human; Immunohistochemistry; Neurokinin 3 receptor; Rat; Tachykinins

Indexed keywords

NEUROKININ 3 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; AROUSAL; ARTICLE; AUTORADIOGRAPHY; BRAIN PROTECTION; BRAIN REGION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

AMINO ACID SEQUENCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; CONSENSUS SEQUENCE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; NERVE FIBERS; NEURONS; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; RATS; RECEPTORS, NEUROKININ-3; SPINAL CORD; SUBSTANCE P;

EID: 0033049137     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00349-2     Document Type: Article

References (72)

1. Arenas E., Pérez-Navarro E., Alberch J., Marsal J. Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum. Brain Res. 603:1993;317-320.
2. Buck S.H., Burcher E., Shults C.W., Lovenberg W., O'Donohue T.L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science. 226:1984;987-989.
3. Buck S.H., Helke C.J., Burcher E., Shults C.W., O'Donohue T.L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat nervous system. Peptides. 7:1986;1109-1120.
4. Buell G., Schulz M.F., Arkinstall S.J., Maury K., Missotten M., Adami N., Talabot F., Kawashima E. Molecular characterization, expression and localization of human neurokinin-3 receptor. Fedn Eur. biochem. Socs J. 299:1992;90-95.
5. Bunnett N.W., Dazin P.F., Payan D.G., Grady E.F. Characterization of receptors using cyanine 3-labeled neuropeptides. Peptides. 16:1995;733-740.
6. Calvo N., Reiriz J., Pérez-Navarro E., Alberch J. Tachykinins protect cholinergic neurons from quinolinic acid excitotoxicity in striatal cultures. Brain Res. 740:1996;323-328.
7. Carter M.S., Krause J.E. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide Y. J. Neurosci. 10:1990;2203-2214.
8. Chung F.Z., Wu L.H., Vartanian M.A., Watling K.J., Guard S., Woodruff G.N., Oxender D.L. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors. Biochem. biophys. Res. Commun. 198:1994;967-972.
9. Ciofi P., Krause J.E., Prins G.S., Mazzuca M. Presence of nuclear androgen receptor-like immunoreactivity in neurokinin B-containing neurons of the hypothalamic arcuate nucleus of the adult rat. Neurosci. Lett. 182:1994;193-196.
10. Couture R., Picard P., Poulat P., Prat A. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. Can. J. Physiol. Pharmac. 73:1995;892-902.
11. Dam T.V., Escher E., Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res. 453:1988;372-376.
12. Danks J.A., Rothman R.B., Cascieri M.A., Chicchi G.G., Liang T., Herkenham M. A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain. Brain Res. 385:1986;273-281.
13. Dietl M.M., Palacios J.M. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res. 539:1991;211-222.
14. Ding Y.Q., Shigemoto R., Takada M., Ohoshi H., Nakanishi S., Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J. comp. Neurol. 364:1996;290-310.
15. Elliott P.J., Paris J.M., Mitsushio H., Lorens S.A. Neuronal sites mediating locomotor hyperactivity following central neurokinin agonist administration. Pharmac. Biochem. Behav. 37:1990;329-333.
16. Gether U., Johansen T.E., Schwartz T.W. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. J. biol. Chem. 268:1993;7893-7898.
17. Guard S., Watson S.P. Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18:1991;149-165.
18. Harlow E. and Lane D. (1988) Antibodies, a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, U.S.A.
19. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. Fedn Am. Socs exp. Biol. J. 4:1990;1606-1615.
20. Henriksen J.S., Saermark T., Vilhardt H., Mau S.E. Tachykinins induce secretion of prolactin from perifused rat anterior pituitary cells by interactions with two different binding sites. J. Rec. Sig. Transd. Res. 15:1995;529-541.
21. Huang R.R. C., Cheung A.H., Mazina K.E., Strader C.D., Fong T.M. cDNA sequence and heterologous expression of the human neurokinin-3 receptor. Biochem. biophys. Res. Commun. 168:1992;966-972.
22. Humpel C., Saria A. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Neurosci. Lett. 157:1993;223-226.
23. Krause J. E., Sachais B. S. and Blount P. (1994) Tachykinin receptors. In Handbook of Receptors and Channels (ed Peroutka S. J.), pp. 277-298. CRC, Ann Arbor.
24. 7]neurokinin B, and is responsive to tachykinin peptide agonists. Proc. natn. Acad. Sci. U.S.A. 94:1997;310-315.
25. Laniyonu A., Sliwinski-Lis E., Fleming N. Different tachykinin receptor subtypes are coupled to the phosphoinositide or cyclic AMP signal transduction pathways in rat submandibular cells. Fedn Eur. biochem. Socs Lett. 240:1988;186-190.
26. Lebrun C.J., Wende P., Steckelings U., Unger Th. Effects of tachykinins on phosphoinositide metabolism in the hypothalamus: is the NK1 receptor involved? Brain Res. 632:1993;74-79.
27. Lorens S.A., Kindel G., Dong X.W., Lee J.M., Hanin I. Septal choline acetyltransferase immunoreactive neurons: dose-dependent effects of AF64A. Brain Res. Bull. 26:1991;965-971.
28. MacDonald M.R., Takeda J., Rice C.M., Krause J.E. Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, α-, β-, and γ-preprotachykinin. J. biol. Chem. 264:1989;15578-15592.
29. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmac. 26:1995;911-944.
30. Maggio J.E. Tachykinins. A. Rev. Neurosci. 11:1988;13-28.
31. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. comp. Neurol. 350:1994;412-438.
32. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:1989;258-279.
33. Marksteiner J., Sperk G., Krause J.E. Distribution of neurons expressing neurokinin B in the rat brain: immunohistochemistry and in situ hybridization. J. comp. Neurol. 317:1992;341-356.
34. McCarson K.E., Krause J.E. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci. 14:1994;712-720.
35. Morel G. Internalization and nuclear localization of peptide hormones. Biochem. Pharmac. 47:1994;63-76.
36. 125I]-Bolton-Hunter scyliorhinin II: a novel, selective radioligand for the tachykinin NK3 receptor in rat brain. Peptides. 11:1990;827-836.
37. Mussap C.J., Geraghty D.P., Burcher E. Tachykinin receptors: a radioligand binding perspective. J. Neurochem. 60:1993;1987-2009.
38. Nakanishi S. Mammalian tachykinin receptors. A. Rev. Neurosci. 14:1991;123-136.
39. Nakanishi S., Nakajima Y., Yokota Y. Signal transduction and ligand-binding domains of the tachykinin receptors. Regul. Pept. 46:1993;37-42.
40. Nakayama Y., Takano Y., Saito R., Kamiya H. Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus. Brain Res. 595:1992;339-342.
41. Nguyen Q.T., Jukic D., Chretien L., Gobeil F., Boussougou M., Regoli D. Two NK-3 receptor subtypes: demonstration by biological and binding assays. Neuropeptides. 27:1994;157-161.
42. O'Donohue T. L., Helke C. J., Shults C. W., Buck S. H. and Burcher E. (1990) Tachykinin receptors. In Handbook of Chemical Neuroanatomy (eds Bjorklund A., Hokfelt T. and Kuhar M. J.), Vol. 9, pp. 395-442. Neuropeptides in the CNS, Part II, Elsevier, Amsterdam.
43. Paris J.M., Lorens S.A. Intra-median raphe infusions of muscimol and the substance P analogue DiMe-C7 produce hyperactivity: role of serotonin neurons. Brain Res. 26:1987;139-151.
44. Paris J.M., Lorens S.A. A dose-response analysis of intra-raphe tachykinin-induced hyperactivity. J. Pharmac. exp. Ther. 251:1989;388-393.
45. Petitet F., Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea pig but not in the rat. Biochem. biophys. Res. Commun. 191:1993;180-187.
46. Quirion R., Mount H., Dam T. V., Boksa P., Buck S., Burcher E. and O'Donohue T. L. (1987) Neurokinin receptors in human brain. In Substance P and Neurokinins (eds Henry J. L., Couture R., Cuello A. C., Pelletier G., Quirion R. and Regoli D.), pp. 363-365. Springer-Verlag, New York.
47. Rance N., Bruce T.R. Neurokinin B gene expression is increased in the arcuate nucleus of ovariectomized rats. Neuroendocrinology. 60:1994;337-345.
48. Regoli D., Boudon A., Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmac. Rev. 46:1994;551-599.
49. Regoli D., Nantel F. Pharmacology of neurokinin receptors. Biopolymers. 31:1991;777-783.
50. Regoli D., Nguyen Q.T., Jukic D. Neurokinin receptor subtypes characterized by biological assays. Life Sci. 54:1994;2035-2047.
51. Roder C., Bellmann R., McCarson K.E., Krause J.E., Sperk G. Kainic acid induced seizures cause a marked increase in the expression of neurokinin-3 receptor mRNA in the rat cerebellum. Neurosci. Lett. 181:1994;158-160.
52. Saffroy M., Beaujouan J.C., Torrens Y., Besseyre J., Bergstrom L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 9:1988;227-241.
53. Schmidt P., Schroder H., Maderspach K., Staak M. Immunohistochemical localization of kappa opioid receptors in the human frontal cortex. Brain Res. 654:1994;223-233.
54. Seabrook G.R., Bowery B.J., Hill R.G. Pharmacology of tachykinin receptors on neurons in the ventral tegmental area of rat brain slices. Eur. J. Pharmac. 273:1995;113-119.
55. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J. biol. Chem. 265:1990;623-628.
56. Shults C.W., Quirion R., Chronwall B., Chase T.N., O'Donohue T.L. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5:1984;1097-1128.
57. Simonin F., Gaveriaux-Ruff C., Befort K., Matthes H., Lannes B., Micheletti G., Mattei M.G., Charron G., Bloch B., Kieffer B. Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. natn. Acad. Sci. U.S.A. 92:1995;7006-7010.
58. Stoessl A.J., Dourish C.T., Iversen S.D. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT. Brain Res. 517:1990;111-116.
59. Stoessl A.J., Dourish C.T., Iversen S.D. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats. Br. J. Pharmac. 94:1988;285-287.
60. Stoessl A.J., Dourish C.T., Iversen S.D. The NK-3 tachykinin receptor agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. Psychopharmacology. 95:1988;502-506.
61. 3H]senktide. Brain Res. 534:1990;1-7.
62. Stoessl A.J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res. 646:1994;13-18.
63. Tachado S.D., Akhtar R.A., Yousufzai S.Y. K., Abdel-Latif A.A. Species differences in the effects of substance P on inositol triphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: differences in receptor density. Expl Eye Res. 53:1991;729-739.
64. Takano Y., Nakayama Y., Matsumoto T., Saito R., Kamiya H. The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats. Regul. Pept. 46:1993;360-363.
65. Tsuchida K., Shigemoto R., Yokota Y., Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur. J. Biochem. 193:1990;751-757.
66. Wenk G.L., Rance N.E., Mobley S.L. Effects of excitatory amino acid lesions upon neurokinin B and acetylcholine neurons in the nucleus basalis of the rat. Brain Res. 679:1995;8-14.
67. Wormser U., Laufer R., Hart Y., Chorev M., Gilon C., Selinger Z. Highly selective agonists for substance P receptor subtypes. Eur. molec. Biol. Org. J. 5:1986;2805-2808.
68. Xie G.-X., Miyajima A., Goldstein A. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. Proc. natn. Acad. Sci. U.S.A. 89:1992;4124-4128.
69. Zerari F., Karpitskiy V., Krause J., Descarries L., Couture R. Immunoelectron microscopic localization of NK-3 receptor in the rat spinal cord. NeuroReport. 8:1997;2661-2664.
70. Zhang L., Harlan R.E. Ontogeny of the distribution of tachykinins in rat cerebral cortex: immunocytochemistry and in situ hybridization histochemistry. Devl Brain Res. 77:1994;23-26.
71. Zhu J., Chen C., Xue J.C., Kunapuli S., DeRiel J.K., Liu-Chen L.Y. Cloning of a human kappa opioid receptor from the brain. Life Sci. 56:1995;201-207.
72. Zhuo H., Helke C.J. Neurokinin B peptide-2 neurons project from the hypothalamus to the thoracolumbar spinal cord of the rat. Neuroscience. 52:1993;1019-1028.